Cannabis stocks and the Cronos Group in particular have been “blazing” trails since day one as this investment firm became the first to list on any major U.S exchange. The Cronos Group Inc. seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana primarily for Canada’s Medical Purposes Regulations.
Looking at the performance of some Cannabis stocks over the last 12 months it is noticeable from looking at ETFMG Alternative Harvest ETF (MJ) (blue line) that the stocks gained momentum late last year and are starting to move lower.
Take note, that the cannabis market is really in its infancy and this move lower might be the start of a (seasonal) trend forming, the same as which we find in commodity stocks.
Source - Bloomberg
Earnings and Outlook
The recent Q4 earnings released late March 2019 which did not exceed analysts’ expectations and was not completely unexpected. The firm still managed net revenue of over $15 million for the year and a gross profit of $8 million.
Despite the lack lustre earnings, recent investments and joint ventures will continue to make the Cronos Group an attractive company to invest in over the long term. From looking at the NASDAQ chart below we can see how Cronos (green line) stacked up against the NASDAQ index (blue line). The NASDAQ has gained 20.68% year to date, while Cronos gained over 50% over the same period.
Source - CNN Business
Looking at the technical chart of The Cronos Group Inc. (CRON) we can see the price action broke out of the base at $13.93 per share and gained momentum. The price action is moving lower from its highs back toward the base, which is now support. The price needs to move higher which might give us an opportunity to invest above $19.39 per share. Our target price might possibly be back to the highs around $23.76 per share.
Source - Bloomberg
- Portfolio Hold (Current).
- Portfolio Buy opportunity above $19.39 (Future).
- #WhatsTheBeef portfolio target price: $420 (just kidding), $23.76 (Future)
Know your company: Cronos Group Inc. (CRON)
- The Cronos Group was the first cannabis company to list to a major U.S exchange and currently trades on the NASDAQ as well as Canada’s TSX Venture exchange.
- Altria Group Inc. (MO) made Cronos Group its exclusive partner and bought a 45% equity stake worth close to $1.8 Billion.
Follow Barry Dumas
Barry is a market analyst with GT247, with a wealth of experience in the investment markets. Now in his tenth year in the markets, Barry "The Beef" Dumas brings a combination of technical analysis and fundamental insights to the table.